A detailed history of Ritter Daniher Financial Advisory LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ritter Daniher Financial Advisory LLC holds 350 shares of NVO stock, worth $36,771. This represents 0.01% of its overall portfolio holdings.

Number of Shares
350
Previous 350 -0.0%
Holding current value
$36,771
Previous $49,000 16.33%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $15,914 - $34,919
175 Added 100.0%
350 $31,000
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $23,159 - $27,849
175 New
175 $27,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ritter Daniher Financial Advisory LLC Portfolio

Follow Ritter Daniher Financial Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritter Daniher Financial Advisory LLC , based on Form 13F filings with the SEC.

News

Stay updated on Ritter Daniher Financial Advisory LLC with notifications on news.